| Literature DB >> 30951658 |
Alan Trounson1, Nicholas R Boyd2, Richard L Boyd2.
Abstract
In this issue of Cell Stem Cell, Xu et al. (2019) demonstrate that editing iPSCs' major histocompatibility antigens may potentially provide a small set of universally compatible stem cell lines for therapies. However, these modifications may result in patient minor histocompatibility responses and deficiencies in their T cell response repertoire to infection and cancer.Entities:
Mesh：
Year: 2019 PMID： 30951658 DOI： 10.1016/j.stem.2019.03.003
Source DB: PubMed Journal: Cell Stem Cell ISSN： 1875-9777 Impact factor: 24.633